Thomas H. Kean, Representative
sell disclosed on 19 Feb 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
Thomas H. Kean, Representative
sell disclosed on 19 Feb 2026 via House STOCK Act disclosures
Jefferson Shreve, Representative
sell disclosed on 22 Jun 2025 via House STOCK Act disclosures
Rob Bresnahan, Representative
buy disclosed on 8 May 2025 via House STOCK Act disclosures
Gilbert Cisneros, Representative
sell disclosed on 6 Mar 2025 via House STOCK Act disclosures
Daniel Goldman, Representative
sell disclosed on 19 May 2023 via House STOCK Act disclosures
Daniel Goldman, Representative
sell disclosed on 19 May 2023 via House STOCK Act disclosures
Daniel Goldman, Representative
buy disclosed on 24 Feb 2023 via House STOCK Act disclosures
Thomas Suozzi, Representative
sell disclosed on 19 Dec 2022 via House STOCK Act disclosures
Thomas Suozzi, Representative
sell disclosed on 19 Dec 2022 via House STOCK Act disclosures
Thomas Suozzi, Representative
buy disclosed on 19 Dec 2022 via House STOCK Act disclosures
Thomas Suozzi, Representative
buy disclosed on 20 May 2022 via House STOCK Act disclosures